pericarditis
Jump to navigation
Jump to search
Introduction
Inflammation of the pericardium.
Largely a clinical & to a lesser extent, electrocardiographic diagnosis.
Etiology
- idiopathic
- infection, especially viral
- acute myocardial infarction
- Dressler's syndrome onset 2-10 weeks post MI
- metastatic neoplasm
- radiation therapy
- 20% if entire pericardium is in field of radiation
- shielding of heart reduces incidence to < 3%
- may occur immediately or months later
- up to 15-20 years later
- pericarditis that occurs during radiation therapy generally does not preclude completion of therapy
- chronic renal failure (uremic pericarditis)
- connective tissue disease
- pharmacologic agents
- autoimmune reaction weeks to months post surgery or MI
- myxedema
- sarcoidosis
- amyloidosis
- associated with severe anemia
- associated with atrial septal defect
- aortic dissection with leakage into pericardial sac
- familial Mediterranean fever
- trauma, thoracic surgery
Epidemiology
- men affected more often than women
- adults affected more often than children
Clinical manifestations
- pleuritic chest pain
- generally presenting symptom
- generally sharp, pleuritic, worsened with inspiration
- may be intense, dull suggesting myocardial ischemia
- positional, relieved by sitting up, leaning forward
- worsened by supine position[20]
- may be worsened by deep breaths or holding breath
- the pericardium has few pain fibers
- pain generally arises from inflammation of adjacent parietal pleura
- persistent pain, hours or days in duration
- fever
- palpitations
- 2-3 component pericardial friction rub on chest auscultation
- may be described as scratchy systolic & diastolic auscultatory sounds
- may be best heard at left sternal border independent of respirations
- described as vibratory systolic murmur[20]
- may occur two days after myocardial infarction
Diagnostic criteria
- chest pain typical of pericarditis (see Clinical manifestations:)
- pericardial friction rub
- new ECG changes (see electrocardiogram)
- pericardial effusion (see echocardiogram)
* 2 of 4 criteria makes diagnosis of acute pericarditis[4]
Laboratory
- complete blood count: Leukocytosis
- elevated erythrocyte sedimentation rate (ESR)
- markers of myocardial infarction may be slightly elevated with myopericarditis[4]
- especially, troponin-I
- leukocytes in pericardial fluid
Diagnostic procedures
- electrocardiogram
- diffuse ST segment elevation
- concave upward
- generally present in all leads except aVR & V1
- days later, ST segment returns to baseline
- absence of reciprocal ST segment depression
- T-wave inversion when ST segment returns to baseline
- atrial premature contractions (APC)
- atrial fibrillation
- differentiate from early repolarization variant (ERV)
- PR segment depression (except aVR)[4]
- electrical alternans (alternating high & low voltage QRS complexes) with large pericardial effusions
- normalization of ST, PR & T wave changes occur late
- no QT prolongation[4]
- anterior Q waves may be observed but no pathologic Q waves[4]
- no reciprocal ST segment or T-wave changes[4]
- diffuse ST segment elevation
- echocardiogram:
- identifies pericardial effusion
- initial testing[20]
- absence of pericardial effusion does not rule out pericarditis[4]
- right atrial inversion suggests early cardiac tamponade
- identifies pericardial effusion
- cardiac catheterization:
- useful in differentiating cardiac tamponade, restrictive cardiomyopathy & constrictive pericarditis
- pericardiocentesis with pericardial biopsy
- rarely indicated
- diagnosis of suspected bacterial, tubercular or systemic inflammatory disease
- pericardial effusion persisting > 3 months
Radiology
- Chest X-ray
- increased size of heart if pericardial effusion > 250 mL
- 'water-bottle' configuration
Complications
- recurrent pericarditis (28%)
- lack to response to NSAIDs & treatment of initial episode with glucocorticoids increases risk of recurrence[4]
- pericardial tamponade
- chronic pericarditis
Differential diagnosis
- unstable angina, myocardial ischemia
- post MI pericarditis mimics unstable angina
- dissecting aneurysm
- sudden, severe onset of pain
- widening of mediastinum
- pneumothorax
- sharp chest pain with dyspnea
- ECG & CXR will distinguish
- pulmonary infarction
- esophageal disorder
- constrictive pericarditis
- abdominal disorder presenting as chest pain
- biliary colic due to cholecystitis or choledocholithiasis
- cardiac tamponade
- hypotension, jugular venous distension
- pulsus paradoxus (decrease in systolic blood pressure > 10 mm Hg during inspiration)[20]
- Dressler's syndrome
- onset of symptoms 2-10 weeks post myocardial infarction
- pericarditis may be a manifestation of Dressler's syndrome
- pleuritis, pleural effusion
Management
- hospitalize if high-risk features
- rule out myocardial infarction
- emergent pericardiocentesis if evidence of pericardial tamponade
- patients without high-risk features (fever, leukocytosis, acute trauma, abnormal cardiac enzymes, immunosuppression, oral anticoagulant use, larger pericardial effusion, evidence of cardiac tamponade) may be managed as outpatients[4]
- pharmacologic agents
- NSAIDS
- colchicine
- hemodialysis for uremic pericarditis including stage G5 chronic kidney disease
- prednisone or other glucocorticoid
- severe pain refractory to NSAIDs & colchicine or contraindications to NSAIDs & colchicine
- not advised for initial therapy of pericarditis
- may increase risk of pericarditis recurrence[20]
- avoid post myocardial infarction as glucocorticoids inhibit myocardial healing
- autoimmune-mediated pericarditis[4]
- uremic pericarditis not responsive to intensive hemodialysis
- 40-60 mg PO QD until improved
- taper by 5 mg every 3 days until 20 mg/day, then taper more slowly
- steroid withdrawal results in recurrence of pain
- months of therapy[4]
- no benefit for tuberculous pericarditis[14]
- codeine 15-30 mg PO every 4 hours
- interleukin-1 trap rilonacept for resolution & prevention of recurrent pericarditis[19]
- non-acetylated salicylate for post-MI pericarditis
- anticoagulants are relatively contraindicated for risk of pericardial hemorrhage
- tuberculous pericarditis
- four drug therapy for tuberculosis
- prednisone[4]
- bedrest until resolution of pain
- immunotherapy
- no benefit for Myvobacterium indicus pranii immunotherapy in patients with tuberculous pericarditis[14]
- patient education
- most cases self-limited resolving in 4-6 weeks
- follow-up:
- echocardiogram if clinical signs of constrictive pericarditis
Notes
- case presentation[15]
More general terms
More specific terms
Additional terms
References
- ↑ Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook, Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 383-85
- ↑ Saunders Manual of Medical Practice, Rakel (ed), WB Saunders, Philadelphia, 1996, pg 268-70
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 50-51
- ↑ 4.00 4.01 4.02 4.03 4.04 4.05 4.06 4.07 4.08 4.09 4.10 4.11 4.12 4.13 4.14 4.15 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2015, 2018, 2022.
Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022 - ↑ Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 1095
- ↑ 6.0 6.1 Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, Ghisio A, Belli R, Trinchero R. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch Intern Med. 2005 Sep 26;165(17):1987-91. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16186468
- ↑ Khandaker MH, Espinosa RE, Nishimura RA et al Pericardial disease: diagnosis and management. Mayo Clin Proc. 2010 Jun;85(6):572-93 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20511488
- ↑ Lotrionte M, Biondi-Zoccai G, Imazio M et al International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J. 2010 Oct;160(4):662-70. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20934560
- ↑ Imazio M, Brucato A, Cemin R et al Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med. 2011 Oct 4;155(7):409-14. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21873705
- ↑ Imazio M, Cecchi E, Ierna S et al Investigation on Colchicine for Acute Pericarditis: a multicenter randomized placebo-controlled trial evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of pericarditis; study design amd rationale. J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):613-7. PMID: https://www.ncbi.nlm.nih.gov/pubmed/17667033
- ↑ Imazio M, Trinchero R. Triage and management of acute pericarditis. Int J Cardiol. 2007 Jun 12;118(3):286-94 PMID: https://www.ncbi.nlm.nih.gov/pubmed/17049636
- ↑ 12.0 12.1 Imazio M et al. for the ICAP Investigators. A randomized trial of colchicine for acute pericarditis. N Engl J Med 2013 Sep 1 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23992557 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1208536
Imazio M, Brucato A, Adler Y. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2014 Feb 20;370(8):781. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24552333 - ↑ 13.0 13.1 Meyer BJ Mounting Evidence Supports Colchicine for Pericarditis. NEJM Journal Watch. May 19, 2014 Massachusetts Medical Society (subscription needed) http://www.jwatch.org
Imazio M et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): A multicentre, double- blind, placebo-controlled, randomised trial. Lancet 2014 Mar 30; PMID: https://www.ncbi.nlm.nih.gov/pubmed/24694983
Cacoub PP. Colchicine for treatment of acute or recurrent pericarditis. Lancet 2014 Mar 30 PMID: https://www.ncbi.nlm.nih.gov/pubmed/24694984 - ↑ 14.0 14.1 14.2 Mayosi BM et al. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis. N Engl J Med 2014 Sep 2 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25178809 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1407380
Chaisson RE and Post WS. Immunotherapy for tuberculous pericarditis. N Engl J Med 2014 Sep 2; <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25178808 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMe1409356 - ↑ 15.0 15.1 LeWinter MM Clinical practice. Acute pericarditis. N Engl J Med 2014; 371:2410-2416. December 18, 2014 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25517707 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMcp1404070
- ↑ Drachman DE, Dudzinski DM, Moy MP Case 27-2017 - A 32-Year-Old Man with Acute Chest Pain. N Engl J Med 2017; 377:874-882. August 31, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28854089 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMcpc1706111
- ↑ Faria D, Freitas A. Images in Clinical Medicine. Tuberculous Pericarditis. N Engl J Med 2018; 378:e27. May 17, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29768154 https://www.nejm.org/doi/full/10.1056/NEJMicm1709552
- ↑ Imazio M. Pericardial involvement in systemic inflammatory diseases. Heart. 2011 Nov;97(22):1882-92. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22016400
- ↑ 19.0 19.1 Klein AL et al. Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis. N Engl J Med 2020 Nov 16; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/33200890 https://www.nejm.org/doi/10.1056/NEJMoa2027892
- ↑ 20.0 20.1 20.2 20.3 20.4 20.5 20.6 NEJM Knowledge+
NEJM Knowledge+ Question of the Week. March 26, 2924 https://knowledgeplus.nejm.org/question-of-week/5082/ - ↑ 21.0 21.1 Imazio M, Brucato A, Forno D et al Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis. Heart. 2012 Jul;98(14):1078-82. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22442198 Review.